ZA972302B - 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. - Google Patents

1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.

Info

Publication number
ZA972302B
ZA972302B ZA9702302A ZA972302A ZA972302B ZA 972302 B ZA972302 B ZA 972302B ZA 9702302 A ZA9702302 A ZA 9702302A ZA 972302 A ZA972302 A ZA 972302A ZA 972302 B ZA972302 B ZA 972302B
Authority
ZA
South Africa
Prior art keywords
trisdehydro
dihydroxy
cholecalciferol derivatives
cholecalciferol
derivatives
Prior art date
Application number
ZA9702302A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA972302B publication Critical patent/ZA972302B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ZA9702302A 1996-03-21 1997-03-17 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives. ZA972302B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
ZA972302B true ZA972302B (en) 1997-09-22

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702302A ZA972302B (en) 1996-03-21 1997-03-17 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.

Country Status (30)

Country Link
EP (1) EP0796843B1 (pt)
JP (1) JP2801587B2 (pt)
KR (1) KR100240541B1 (pt)
CN (1) CN1110477C (pt)
AR (1) AR006315A1 (pt)
AT (1) ATE240941T1 (pt)
AU (1) AU708679B2 (pt)
BR (1) BR9701404A (pt)
CA (1) CA2199893C (pt)
CO (1) CO4820396A1 (pt)
CZ (1) CZ85897A3 (pt)
DE (1) DE69722064T2 (pt)
DK (1) DK0796843T3 (pt)
ES (1) ES2198512T3 (pt)
HR (1) HRP970162A2 (pt)
HU (1) HUP9700609A3 (pt)
ID (1) ID16285A (pt)
IL (1) IL120469A0 (pt)
MA (1) MA26423A1 (pt)
MX (1) MX9702139A (pt)
NO (1) NO971217L (pt)
NZ (1) NZ314424A (pt)
PE (1) PE42998A1 (pt)
PL (1) PL319070A1 (pt)
PT (1) PT796843E (pt)
SG (1) SG70589A1 (pt)
TR (1) TR199700219A3 (pt)
TW (1) TW444001B (pt)
YU (1) YU10397A (pt)
ZA (1) ZA972302B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DE69005897D1 (de) * 1989-05-18 1994-02-24 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
DK0796843T3 (da) 2003-09-15
IL120469A0 (en) 1997-07-13
JP2801587B2 (ja) 1998-09-21
TW444001B (en) 2001-07-01
CN1172793A (zh) 1998-02-11
CO4820396A1 (es) 1999-07-28
ATE240941T1 (de) 2003-06-15
DE69722064D1 (de) 2003-06-26
CZ85897A3 (cs) 1998-04-15
NO971217L (no) 1997-09-22
TR199700219A2 (xx) 1997-10-21
DE69722064T2 (de) 2004-04-08
AR006315A1 (es) 1999-08-25
NO971217D0 (no) 1997-03-17
YU10397A (sh) 1999-07-28
CN1110477C (zh) 2003-06-04
MA26423A1 (fr) 2004-12-20
ID16285A (id) 1997-09-18
AU1513597A (en) 1997-09-25
NZ314424A (en) 1998-07-28
PE42998A1 (es) 1998-08-11
KR100240541B1 (ko) 2000-01-15
HUP9700609A3 (en) 1999-03-01
JPH107651A (ja) 1998-01-13
CA2199893A1 (en) 1997-09-21
SG70589A1 (en) 2000-02-22
CA2199893C (en) 2008-02-05
ES2198512T3 (es) 2004-02-01
PL319070A1 (en) 1997-09-29
MX9702139A (es) 1998-04-30
TR199700219A3 (tr) 1997-10-21
PT796843E (pt) 2003-09-30
BR9701404A (pt) 1998-11-03
HU9700609D0 (en) 1997-05-28
KR970065495A (ko) 1997-10-13
EP0796843B1 (en) 2003-05-21
EP0796843A3 (en) 1999-04-14
AU708679B2 (en) 1999-08-12
HRP970162A2 (en) 1998-04-30
HUP9700609A2 (hu) 1998-07-28
EP0796843A2 (en) 1997-09-24

Similar Documents

Publication Publication Date Title
ZA977687B (en) Substituted 6,5-hetero-bicyclic derivatives
HK1019597A1 (en) Substituted 6, 6-hetero-bicyclic derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
PL331602A1 (en) Pyrido- or pyrimido-substituted 6,6- or 6,7-bicyclic derivatives
ZA9710429B (en) Broad-spectrumδ-endotoxins.
SI0856514T1 (en) 8-substituted-1,3,8-triazaspiro(4.5)decan-4-on derivatives
ZA972056B (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
CY2425B1 (en) 2,4-Diaminopyrimidine derivatives.
ZA945238B (en) 1,5 Benzodiazepine derivatives.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA979725B (en) Benzoaxozole derivative.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA971474B (en) Endothelin-receptor-antagonists.
ZA973409B (en) 3-descladinose-2,3-anhydroerythromycin derivatives.
ZA981956B (en) Saccharin-5-carbonylcyclohexane-1,3,5-trione derivatives.
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives
ZA975469B (en) X14-mannitol.
ZA977881B (en) N-benzylazolium derivatives.